Navigation Judge Sides With Sanofi, Dismissing Patient's Claims Against Cancer Medication Taxotere
The plaintiff sought to file an amended complaint, which would replace her short form complaint that defines “Permanent Chemotherapy Induced Alopecia,” using identical language in which the multidistrict litigation court previously rejected. Chief U.S. District Judge Michael F. Urbanski rejected the plaintiff’s request and agreed with Sanofi as to each of the plaintiff’s claims.
